Untreated periocular discoid lupus erythematosus (DLE), though very rare, may lead to significant morbidity with lid deformities, trichiasis, and symblepharon formation. We present the largest ...

An update to the Cochrane Review of discoid lupus erythematosus (DLE) treatment has found that fluocinonide cream 0.05% may be more effective than hydrocortisone cream 1% in clearing skin lesions ...

Discoid lupus erythematosus laboratory follow-up September 18, 2011 How often should blood tests be repeated to rule out systemic lupus erythematosus (SLE) in a patient positive for discoid lupus ...

Diagnosis of discoid lupus erythematosus in patients aged younger than 25 years may predict the onset of severe systemic lupus erythematosus, according to study findings. “No study assessed risk ...

We will only mention discoid lupus since it is the most common. Discoid lupus is so-named since the rash is often disc-shaped. The rash usually appears on the scalp and face, but sometimes it also ...

Patients with pediatric discoid lupus erythematosus combined with systemic lupus erythematosus were most likely to be older and face single end-organ disease, according to data published in the ...

Discoid lupus erythematosus on the scalp has the same appearance as discoid lupus elsewhere on the face and body. The scalp is the sole skin site affected in 11% to 20%.

Pediatric discoid lupus erythematosus (DLE) carries a significant risk of progression to systemic lupus erythematosus (SLE), according to a new review. Menu SECTIONS. Home; Drug Monographs.

We will only mention discoid lupus since it is the most common. Discoid lupus is so-named since the rash is often disc-shaped. The rash usually appears on the scalp and face, but sometimes it also ...

IN 1954 McCuistion and Schoch1 reported the case of a white newborn infant with possible discoid lupus erythematosus. So far as can be determined this is the only previous report of a child born wi ...

A rare conversion of discoid lupus to antiphospholipid syndrome and systemic lupus erythematosus is presented in a 64-year-old man. What are the related diagnostic and management challenges?

Horizon Therapeutics plc today announced the first patient has enrolled in a Phase 2, randomized, placebo-controlled trial to evaluate its development-stage medicine daxdilimab, a potentially ...